EuroPCR 22: EASTBOURNE Registry LBCT interview

 Bernardo Cortese (Fondazione Ricerca e Innovazione Cardiovascolare, IT) discusses the main findings from the EASTBOURNE Study, that investigated the sirolimus-coated balloon in an all-comer population.

Findings are positive as regards the device’s safety and efficacy profile, with the primary endpoint of target lesion revascularization (TLR) occurring in 6% of the population.

Full interview available here:


EuroPCR 2022 – First Symposium- Current Role of Paclitaxel-DCB in PCI

Fondazione RIC is inviting you.

It is a real pleasure and honor, to share and invite you at the first co-sponsorized symposium on paclitaxel DCB, during EuroPCR 2022. The Course will have the top-in-class Experts on the DCB technology, and will be held in ROOM 252B, Wednesday 18th, 16.30-17.30. Join us if you are attending this years’ EuroPCR!

Home – Fondazione RIC



Course Programme @